Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

9301
1
Launch One Acquisition Corp. Launch One Acquisition Corp. Reports Net Income of $2.6M, Working Capital of $1.1M in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9302
1
PRINCETON CAPITAL CORP Princeton Capital Corporation Reports Significant Declines in Financial Performance for Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9303
1
HEALTHY CHOICE WELLNESS CORP. Healthy Choice Wellness Corp. Reports Revenue Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9304
1
FGI Industries Ltd. FGI Industries Reports 20.6% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9305
1
INTEGRATED BIOPHARMA INC Integrated Biopharma Reports 5.4% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9306
1
Blue Foundry Bancorp Blue Foundry Bancorp Reports Net Loss of $4.0 Million in Q3 2024, Interest Income Rises 6.7%

Via official filing (AI summary) | 6 months ago | 0 comments

9307
1
NATURAL ALTERNATIVES INTERNATIONAL INC Natural Alternatives International Inc. Reports Decline in Financial Performance, Net Loss Increases 185%

Via official filing (AI summary) | 6 months ago | 0 comments

9308
1
Embassy Bancorp, Inc. Embassy Bancorp Reports Mixed Q3 Results, Net Income Down 9.6% Amid Rising Interest Expenses

Via official filing (AI summary) | 6 months ago | 0 comments

9309
1
ProPhase Labs, Inc. ProPhase Labs Reports Significant Revenue Decline and Increased Losses for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9310
1
THUNDER MOUNTAIN GOLD INC Thunder Mountain Gold Reports Financial Challenges, Net Loss, and Going Concern Qualification in 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9311
1
BIOVIE INC. BioVie Inc. Reports Improved Financial Results, Net Loss Decrease, and Ongoing Clinical Trials for Innovative Drug Therapies

Via official filing (AI summary) | 6 months ago | 0 comments

9312
1
BROADWAY FINANCIAL CORP DE Broadway Financial Reports Third Quarter 2024 Financial Results, Highlights Strategic Developments

Via official filing (AI summary) | 6 months ago | 0 comments

9313
1
Associated Capital Group, Inc. Associated Capital Group Reports Mixed Q3 Results with Revenue Growth, Operating Loss, and Special Dividend

Via official filing (AI summary) | 6 months ago | 0 comments

9314
1
Coeptis Therapeutics Holdings, Inc. Coeptis Therapeutics Reports Significant Financial Changes, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9315
1
NATIONAL BANKSHARES INC National Bankshares Reports 7.83% Asset Growth, 16.96% Loan Portfolio Increase Amidst Challenging Profitability and Credit Risk Environment

Via official filing (AI summary) | 6 months ago | 0 comments

9316
1
LGL GROUP INC LGL Group Reports 48.4% Revenue Growth, Net Income Decline in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9317
1
U.S. GoldMining Inc. U.S. GoldMining Reports Net Loss, Decrease in Cash and Cash Equivalents in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9318
1
ADIAL PHARMACEUTICALS, INC. Adial Pharmaceuticals Reports Mixed Financial Results, Raises Concerns Over Liquidity

Via official filing (AI summary) | 6 months ago | 0 comments

9319
1
FS Specialty Lending Fund FS Specialty Lending Fund Reports 73% Increase in Investment Income, Shifts Investment Strategy

Via official filing (AI summary) | 6 months ago | 0 comments

9320
1
STRATUS PROPERTIES INC Stratus Properties Inc. Reports Significant Revenue Growth and Improved Financial Performance in Q3 and YTD 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9321
1
Taysha Gene Therapies, Inc. Taysha Gene Therapies Reports $1.8M Revenue, Net Loss of $25.5M in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9322
1
SUTRO BIOPHARMA, INC. Sutro Biopharma Reports 50% Revenue Decline, Increased Operating Expenses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9323
1
Flora Growth Corp. Flora Growth Corp. Reports Decline in Financial Performance, Net Loss, and Regulatory Challenges

Via official filing (AI summary) | 6 months ago | 0 comments

9324
1
Oncology Institute, Inc. The Oncology Institute Reports 21.8% Revenue Growth, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9325
1
HCM II Acquisition Corp. HCM II Acquisition Corp. Reports $1.07M Net Income in Q3 2024, Focuses on Business Combination

Via official filing (AI summary) | 6 months ago | 0 comments